Browsing by Author Shih, Weichung Joe

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 4 of 4
TitleAuthor(s)Issue Date
 
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis
Journal:Annals of Hematology
Abu-Zeinah, GhaithQin, AlbertGill, HarinderKomatsu, NorioMascarenhas, JohnShih, Weichung JoeZagrijtschuk, OlehSato, ToshiakiShimoda, KazuyaSilver, Richard T.Mesa, Ruben
15-Aug-2024
 
Paradigm-PV: A Global, Randomized, Multicenter, Two-Arm Phase IV Study to Assess the Efficacy and Safety of Ropeginterferon Alfa-2b in Low- and High-Risk Patients with Polycythemia Vera
Journal:Blood
Yacoub, AbdulraheemAbu-Zeinah, GhaithQin, AlbertShih, Weichung JoeDa'na, WaleedTashi, TsewangZagrijtschuk, OlehGeller, RobertGill Harinder
5-Nov-2024
 
PARADIGM-PV: a randomized, multicenter phase 4 study to assess the efficacy and safety of ropeginterferon alfa-2b in patients with low- or high-risk polycythemia vera
Journal:Annals of Hematology
Yacoub, AbdulraheemAbu-Zeinah, GhaithQin, AlbertTashi, TsewangDa’na, WaleedShih, Weichung JoeZagrijtschuk, OlehTsai, Chan-YenGeller, RobertKomatsu, NorioMesa, RubenSingh, Gill Harinder
13-Jan-2025
 
Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study
Journal:The Lancet Haematology
Mesa, RubenGill, HarinderZhang, LeiJin, JieKirito, KeitaKomatsu, NorioQin, AlbertXiao, ZhijianTashi, TsewangShimoda, KazuyaOhishi, KohshiChen, SuningZuo, XuelanShirane, ShuichiHu, YuZhang, SujiangWang, YiTakenaka, KatsutoIchii, MichikoXu, NaShih, Lee-YungLim, Ken-HongLee, Sung-EunBae, Sung HwaTeo, Winnie Z YMaze, DawnOh, Stephen TBose, PrithvirajSato, ToshiakiZagrijtschuk, OlehLin, SheenaShih, Weichung JoeMascarenhas, JohnMasarova, Lucia
1-Nov-2025
Showing results 1 to 4 of 4